KalVista Pharmaceuticals Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/26 Q1

Annual report with FYE transition – amended

Annual report with FYE transition

ended 09/30/25 Q3

ended 07/31/25 Q1

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Treanor Patrick

Sensenig Bethany

News Filter

Chiesi Group Completes Acquisition of KalVista Pharmaceuticals

Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding Its Global Rare Disease Portfolio

Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

Provides Update on Strong EKTERLY® Launch With Preliminary Fourth Quarter and Full Year 2025 Revenue Results

Provides Operational Update and Reports Third Quarter Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC